| Dr Lola Felecia Simpson, LPC | |
|
2573 Rainover Trl, Decatur, GA 30034-2278 | |
| (404) 286-1748 | |
| Not Available |
| Full Name | Dr Lola Felecia Simpson |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 2573 Rainover Trl, Decatur, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033372743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | LPC002858 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lola Felecia Simpson, LPC 2573 Rainover Trl, Decatur, GA 30034-2278 Ph: (404) 286-1748 | Dr Lola Felecia Simpson, LPC 2573 Rainover Trl, Decatur, GA 30034-2278 Ph: (404) 286-1748 |
News Archive
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
Elekta announced today it has received clearance to CE mark Agility, a revolutionary beam-shaping device integrated into the head of a linear accelerator (linac). Patients and clinics will benefit from the speed and reliability of this new MLC design.
As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.
A new report from the Cancer Research UK, released this week, says that England would not be declared smoke free by 2030 as earlier projected if the current smoking trends continue. This target of declaring England smoke free by 2030 was set last year, and researchers state that there is still much work to be done.
Phase I study findings suggest the investigational drug ceritinib is effective in patients with advanced non-small-cell lung cancer with anaplastic lymphoma kinase gene rearrangement, even in those who develop resistance to crizotinib.
› Verified 8 days ago
Robin C Johnson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3523 Moonlight Forest Ct, Decatur, GA 30034 Phone: 770-374-1605 | |
Shaina Gordon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 465 Winn Way, 221, Decatur, GA 30030 Phone: 404-292-3810 | |
Sarah Davison, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 445 Winn Way, Decatur, GA 30030 Phone: 404-294-3836 | |
Giselle Amaris Jacob, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1244 Clairmont Rd Ste 204, Decatur, GA 30030 Phone: 404-818-6535 | |
Mrs. Anna Christina Davis, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 465 Winn Way, Suite 221, Decatur, GA 30030 Phone: 404-292-3810 Fax: 404-292-3848 | |
Jacob Dreiling, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1814 Clairmont Rd, Decatur, GA 30033 Phone: 404-636-1457 Fax: 404-636-7449 | |
Nathaniel Flowers, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3232 Memorial Dr, Decatur, GA 30032 Phone: 678-235-5478 |